Association of serum neurofilament light chain levels with clinicopathology of chronic inflammatory demyelinating polyneuropathy, including NF155 reactive patients
Serum neurofilament light chains (NfLs) serve as a biomarker of axonal damage in patients with chronic inflammatory demyelinating polyneuropathy. Serum NFL levels were significantly higher in people with CIDP than in healthy individuals. Serum NFL correlated with pathological indices of axonal degeneration and may serve as a biomarker that reflects active axonal damage of CIDP.

Related Post